Skip to main content

and
  1. Article

    Open Access

    Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy

    Chimeric antigen receptor T cell (CAR-T) therapy is an effective treatment for B cell malignancies. A certain fraction of patients, however, experience post-CAR-T relapse, and due to the difficulty of precise ...

    Naokazu Nakamura, Tomoyasu Jo, Yasuyuki Arai in Clinical and Experimental Medicine (2024)

  2. No Access

    Article

    KyoTox-e score; prediction of post-CAR-T prolonged thrombocytopenia using peripheral blood data before apheresis

    Tomoyasu Jo, Yasuyuki Arai, Toshio Kitawaki in Bone Marrow Transplantation (2024)

  3. Article

    Open Access

    Risk analysis of fluctuating hypercalcemia after leukapheresis in cellular therapy

    Optimized management of citrate-induced hypocalcemia is required to provide safe leukapheresis. We prospectively analyzed subjects who underwent leukapheresis for cytotherapy, and evaluated serum ionized (iCa)...

    Tomoyasu Jo, Yasuyuki Arai, Toshio Kitawaki, Momoko Nishikori in Scientific Reports (2023)

  4. No Access

    Article

    Successful treatment with cyclosporine of pure red cell aplasia induced by obinutuzumab bendamustine therapy

    Yutaka Shimazu, Chisaki Mizumoto, Kazuhisa Chonabayashi, Yuta Hanyu in Annals of Hematology (2023)

  5. No Access

    Article

    An adult case of refractory autoimmune neutropenia after liver transplantation

    Autoimmune neutropenia (AIN) is an exceptionally rare condition that occurs after liver transplantation. Here, we report an adult case of refractory AIN 3.5 years after liver transplantation. A 59-year-old man...

    Huye Sun, Fumiya Wada, Junya Kanda, Chisaki Mizumoto in International Journal of Hematology (2023)

  6. No Access

    Article

    Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome

    VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is caused by UBA1 somatic mutations and is characterized by late-onset systemic autoimmune inflammation and blood abnormalities such as cy...

    Asami Kataoka, Chisaki Mizumoto, Junya Kanda in International Journal of Hematology (2023)

  7. Article

    Open Access

    T-cell counts in peripheral blood at leukapheresis predict responses to subsequent CAR-T cell therapy

    Prediction of responses to chimeric antigen receptor (CAR)-T cell therapies is essential to maximize their therapeutic efficacy for diffuse large B-cell lymphoma (DLBCL). While several tumor-intrinsic risk fac...

    Fumiya Wada, Tomoyasu Jo, Yasuyuki Arai, Toshio Kitawaki in Scientific Reports (2022)

  8. No Access

    Article

    Successful allogeneic bone marrow transplantation in a case of variant acute promyelocytic leukemia with ZBTB16-RARA

    Suguru Morimoto, Tadakazu Kondo, Tomohiro Taya, Hidemasa Matsuo in Annals of Hematology (2022)

  9. No Access

    Article

    An AKI biomarker lipocalin 2 in the blood derives from the kidney in renal injury but from neutrophils in normal and infected conditions

    Lipocalin 2 (LCN2 or neutrophil gelatinase-associated lipocalin) is a secretory protein discovered from neutrophils, which accumulates in the blood and urine during acute kidney injury (AKI) and in the blood b...

    Junya Kanda, Kiyoshi Mori, Hiroshi Kawabata in Clinical and Experimental Nephrology (2015)

  10. No Access

    Article

    Differing impacts of pretransplant serum ferritin and C-reactive protein levels on the incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

    Studies have suggested an association between pretransplant serum levels of ferritin and C-reactive protein (CRP) and complications of allogeneic hematopoietic stem cell transplantation (HSCT). To evaluate the...

    Soichiro Sakamoto, Hiroshi Kawabata, Junya Kanda in International Journal of Hematology (2013)

  11. No Access

    Article

    Acidic milieu augments the expression of hepcidin, the central regulator of iron homeostasis

    Hepcidin is the central regulator of body iron homeostasis, and dysregulation of hepcidin expression causes various clinical disorders, such as anemia and hemochromatosis. Various stimuli, including iron load ...

    Chisaki Mizumoto, Hiroshi Kawabata, Tatsuki Uchiyama in International Journal of Hematology (2012)

  12. Article

    Numerous aggregates of “tiny” micromegakaryocytes in the bone marrow

    Yataro Yoshida, Yoko Hamakawa, Shigeru Oguma in International Journal of Hematology (2010)

  13. No Access

    Article

    The duration of functioning of a subcutaneous implantable port for the treatment of hematological tumors: a single institution-based study

    Although subcutaneous implantable ports have been indicated as venous access for chemotherapy, these devices have not been used routinely for hematological tumors.

    Hitoshi Ohno, Chisaki Mizumoto in International Journal of Clinical Oncology (2010)

  14. No Access

    Article

    MALT lymphoma of the thymus with Sjögren’s syndrome: biphasic changes in serological abnormalities over a 4-year period following thymectomy

    Thymic mucosa-associated lymphoid tissue (MALT) lymphoma shows distinct immunological characteristics, such as the expression of the IgA isotype, the frequent presence of immunoglobulin abnormalities, and a st...

    Takashi Sakamoto, Kouhei Yamashita, Chisaki Mizumoto in International Journal of Hematology (2009)

  15. No Access

    Article

    Mycophenolate mofetil combined with tacrolimus and minidose methotrexate after unrelated donor bone marrow transplantation with reduced-intensity conditioning

    We evaluated the efficacy of a post-grafting immunosuppressive regimen consisting of tacrolimus, methotrexate, and mycophenolate mofetil (MMF) in 21 adults (median age, 55 years) with poor-risk hematologic mal...

    Chisaki Mizumoto, Junya Kanda, Tatsuo Ichinohe in International Journal of Hematology (2009)

  16. No Access

    Article

    Leukemic and meningeal relapse of CD5+ intravascular large B-cell lymphoma with down-modulation of CD20 after rituximab therapy

    Although CD20- relapses of B-cell lymphoma following rituximab therapy have increasingly been reported recently, coexistence of both the original and selected clones on relapse in a single patient have not been d...

    Tatsuharu Ohno, Takashi Sakamoto, Chisaki Mizumoto in International Journal of Hematology (2006)